Literature DB >> 18005265

SHIP-1 protein level and phosphorylation status differs between CLL cells segregated by ZAP-70 expression.

María Laura Gabelloni, Mercedes Borge, Jeremías Galletti, Cristian Cañones, Paula Fernández Calotti, Raimundo Fernando Bezares, Julio Sánchez Avalos, Mirta Giordano, Romina Gamberale.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18005265     DOI: 10.1111/j.1365-2141.2007.06891.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib.

Authors:  Davorka Messmer; Jessie-F Fecteau; Morgan O'Hayre; Ila S Bharati; Tracy M Handel; Thomas J Kipps
Journal:  Blood       Date:  2010-11-15       Impact factor: 22.113

2.  Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis.

Authors:  Morgan O'Hayre; Catherina L Salanga; Thomas J Kipps; Davorka Messmer; Pieter C Dorrestein; Tracy M Handel
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

3.  Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells.

Authors:  Elizabeth A Lemm; Beatriz Valle-Argos; Lindsay D Smith; Johanna Richter; Yohannes Gebreselassie; Matthew J Carter; Jana Karolova; Michael Svaton; Karel Helman; Nicola J Weston-Bell; Laura Karydis; Chris T Williamson; Georg Lenz; Jeremy Pettigrew; Curtis Harwig; Freda K Stevenson; Mark Cragg; Francesco Forconi; Andrew J Steele; Jennifer Cross; Lloyd Mackenzie; Pavel Klener; Graham Packham
Journal:  Clin Cancer Res       Date:  2019-12-12       Impact factor: 12.531

Review 4.  The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy.

Authors:  Graham Packham; Serge Krysov; Alex Allen; Natalia Savelyeva; Andrew J Steele; Francesco Forconi; Freda K Stevenson
Journal:  Haematologica       Date:  2014-07       Impact factor: 9.941

5.  Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia.

Authors:  Veronika Ecker; Martina Stumpf; Lisa Brandmeier; Tanja Neumayer; Lisa Pfeuffer; Thomas Engleitner; Ingo Ringshausen; Nina Nelson; Manfred Jücker; Stefan Wanninger; Thorsten Zenz; Clemens Wendtner; Katrin Manske; Katja Steiger; Roland Rad; Markus Müschen; Jürgen Ruland; Maike Buchner
Journal:  Nat Commun       Date:  2021-06-10       Impact factor: 14.919

6.  The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions.

Authors:  Samantha D Pauls; Sandrine T Lafarge; Ivan Landego; Tingting Zhang; Aaron J Marshall
Journal:  Front Immunol       Date:  2012-08-09       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.